NRG Therapeutics Announces £16 million Series A to Adva

£16 million Series A led by Omega Funds, to advance disease-modifying oral medicines for debilitating chronic neurodegenerative disorders through IND-enabling...

Related Keywords

Australia , Melbourne , Victoria , Stevenage , Hertfordshire , United Kingdom , Katie Kerfoot , Neil Miller , Francesco Draetta , Jonathan Tobin , Sue Charles , Linkedin , Eliza Hall Institute Of Medical Research , Parkinson Foundation , Twitter , Therapeutics Ltd , Michaelj Fox Foundation , Omega Fund , Omega Funds , Amyotrophic Lateral Sclerosis , Seth Masters , Brandon Capital , Omega Funds Managing Director Claudio Nessi , Partner Francesco Draetta , Brandon Capital Partner Jonathan Tobin , Professor Seth Masters , Eliza Hall Institute , Medical Research , Professor Masters , Stevenage Bioscience Catalyst , Managing Director , Virtual Biotech , Charles Consultants , Innovate United Kingdom , Biomedical Catalyst Award , Nrg Therapeutics Ltd ,